University of Lagos, Nigeria
14
2
2
7
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
7.1%
1 terminated/withdrawn out of 14 trials
87.5%
+1.0% vs industry average
36%
5 trials in Phase 3/4
0%
0 of 7 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (14)
The Genetic Basis of Congenital Heart Disease in Africa
Role: collaborator
EMUs: Enhanced Monitoring Using Sensors After Surgery
Role: collaborator
Oral Sildenafil Citrate to Improve Maternal and Neonatal Outcomes in Low-resource Settings
Role: collaborator
Preventing Pulmonary Complications in Surgical Patients at Risk of COVID-19
Role: collaborator
Low Dose Aspirin for Preventing Intrauterine Growth Restriction and Preeclampsia in Sickle Cell Pregnancy (PIPSICKLE)
Role: lead
Effect of Collagen Matrix Graft on Palatal Fistula Formation After Cleft Palate Repair
Role: collaborator
Efficacy of Celsi Warmer for the Management of Hypothermic Newborns at the Lagos University Teaching Hospital in Lagos, Nigeria
Role: collaborator
Iron Infusion Into a Vein Compared to Iron Tablet Taken by Mouth for Treating Iron Deficiency Anemia in Pregnancy (IVON)
Role: lead
Mobile Virtual Simulation Training in Essential Newborn Care for Healthcare Workers in Low and Middle Income Countries
Role: collaborator
MicroRNA Profiles in Triple Negative Breast Cancer
Role: collaborator
Physiotherapy as a Complimentary Treatment in Reducing Viral-Load, Complications, Death, Expedite Discharge and Improve Quality of Life, Exercise Endurance and Capacity in Stroke Survivors With CoViD-19: A Clinical-Controlled Study
Role: lead
The Pan African Pulmonary Hypertension Cohort Study
Role: collaborator
Clinical Performance Evaluation of Fyodor Urine Malaria Test (UMT)
Role: collaborator
Antioxidant Micronutrients in Malaria
Role: lead
All 14 trials loaded